AALL1732
OPEN TO ACCRUAL
Phase 3 Inotuzumab Ozogamicin for Newly Dx HR B ALL plus MPAL and Disseminated B LLy
AAML1831
OPEN TO ACCRUAL
Phase 3 Study for AML Comparing Standard Therapy to CPX-351 plus Gilteritinib for FLT3
ACCL1931
OPEN TO ACCRUAL
Ph3 Levocarnitine Prophylaxis for AYA in ALL Therapy
APAL2020SC
OPEN TO ACCRUAL
PedAL Screening Trial - Developing new therapies for Relapsed Leukemias.
ARAR2331
OPEN TO ACCRUAL
Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)
PIDTC6906
OPEN TO ACCRUAL
PIDTC6906 A Study of PIRD Disorder